ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for pro Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.

AURA Aura Biosciences Inc

7.33
0.13 (1.81%)
Jun 14 2024 - Closed
Delayed by 15 minutes

Period:

Draw Mode:

Volume 88,484
Bid Price 7.11
Ask Price 8.18
News (2)
Day High 7.38

Low
5.99

52 Week Range

High
13.28

Day Low 6.95
Share Name Share Symbol Market Stock Type
Aura Biosciences Inc AURA NASDAQ Common Stock
  Price Change Price Change % Share Price Last Trade
0.13 1.81% 7.33 19:00:00
Open Price Low Price High Price Close Price Previous Close
7.06 6.95 7.38 7.33 7.20
Trades Shares Traded VWAP Financial Volume Average Volume 52 Week Range
1,218 88,484 US$ 7.23 US$ 639,622 - 5.99 - 13.28
Last Trade Type Quantity Price Currency
15:05:05 priorref 5,500 US$ 7.33 USD

Aura Biosciences Inc Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
281.59M 38.26M - 0 -76.41M -2.00 -
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- - - -

more financials information »

Aura Biosciences News

Date Time Source News Article
6/14/202415:42Edgar (US Regulatory)Form DEFA14A - Additional definitive proxy soliciting..
6/14/202415:37Edgar (US Regulatory)Form 10-K/A - Annual report [Section 13 and 15(d), not S-K..
6/04/202416:07Edgar (US Regulatory)Form 8-K - Current report
5/30/202415:05GlobeNewswire Inc.Aura Biosciences to Participate in the Jefferies Global..
5/23/202407:00GlobeNewswire Inc.Aura Biosciences to Host Virtual KOL Event “Pioneering a New..
5/09/202406:10Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]
5/09/202406:05Edgar (US Regulatory)Form 8-K - Current report
5/09/202406:00GlobeNewswire Inc.Aura Biosciences Reports First Quarter 2024 Financial..
5/08/202406:00GlobeNewswire Inc.Aura Biosciences to Participate in Upcoming Investor..
3/27/202406:00Business WireAura Biosciences Reports Fourth Quarter and Full Year 2023..
3/04/202416:35Edgar (US Regulatory)Form 144 - Report of proposed sale of securities
2/26/202406:00Business WireAura Biosciences to Participate in Upcoming Investor..
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....


No posts yet, be the first! No AURA Message Board. Create One! See More Posts on AURA Message Board See More Message Board Posts

Historical AURA Price Data

Period † Open High Low VWAP Avg. Daily Vol Change %
1 Week7.367.736.957.25106,904-0.03-0.41%
1 Month7.247.846.647.32190,5370.091.24%
3 Months8.558.746.647.41146,592-1.22-14.27%
6 Months8.689.726.647.89173,096-1.35-15.55%
1 Year12.5013.285.998.41150,503-5.17-41.36%
3 Years14.1026.165.9911.18114,158-6.77-48.01%
5 Years14.1026.165.9911.18114,158-6.77-48.01%

Aura Biosciences Description

Aura Biosciences Inc is a clinical-stage oncology company developing a novel technology platform based on virus-like drug conjugates to target and destroy cancer cells selectively while activating the immune system to create long-lasting anti-tumor immunity.

Your Recent History

Delayed Upgrade Clock